Chargement en cours...
Immune checkpoint inhibitor-induced takotsubo syndrome and diabetic ketoacidosis: rare reactions
Immune checkpoint inhibitors (ICIs) are increasingly used to treat certain malignancies due to their higher efficacy compared with conventional chemotherapy. As familiarity with these agents increases, it is becoming apparent that a significant number of patients treated with ICIs experience adverse...
Enregistré dans:
| Publié dans: | BMJ Case Rep |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7852999/ https://ncbi.nlm.nih.gov/pubmed/33526518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-237217 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|